Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa3g03044 | ATGGTAGAAGAAAAAGGGTTTGTGCTTTTGCTCTATGGTGCTGCGGAACACAAGACGAGGTTTTCGATGTTTCATACTACATTGTTGTTTCTCGTGTTGTTGGTTCTTTCTCCATTTGCATTTTCACTCACTGATGAAGGACAAGCATTAATGGCAATGAAGTCTTCATTCAACAACATTGCTGACGTTCTTCTTGACTGGGATGATGTGCATAATGACGACTTTTGTTCATGGCGTGGAGTTTTTTGTGATAATGTCACTCTTACTGTAACAGTGGTATCTCTGAACTTGTCATGCTTGAATCTTGGTGGTGAAATATCTCCAGCAATTGGTGATTTAAGAAACTTGCAATCCATAGACCTGCAAGGGAATAAGCTAACTGGTCAAATCCCTGATGAAATTGGGAACTGTGGTGAACTTGTTCATCTGGATTTATCTGATAATCAGCTCTATGGTGATATACCTTTCTCCATATCAAAGCTGAAGCTACTTGAATTTTTGAATTTGAAGAACAATCAGTTGACTGGTCCTATTCCTTCAACTTTATCACAAATTCCAAATCTAAAGACTATTGATCTTGCTAGAAATAAGTTCATTGGAGAAATACCAAGGCTACTCTATTGGAATGAAGTATTGCAATACCTTGGGTTGCGAGGGAATATGTTGACTGGAATTTTGTCTCCCGACATTTGTCAATTAACTGGTTTATGGTACTTTGATGTCAGAGGCAATAATTTGACTGGTACTATACCTGAGAGCATTGGCAACTGTACAAGTTTTGAAATCTTTGACATATCGTATAATCAGATTACTGGGGAGATTCCATATAACATTGGATTTCTTCAAGTGGCTACTTTGTCGCTTCAAGGAAATAGGTTAACCGGGAAGATACCAGAGGTGATTGGTTTGATGCAAGCTCTTGCAATTTTGGATTTGAGTGAGAATCTGTTGGTGGGACCAATTCCTCCAATATTAGGAAATCTATCTTTCACTGGCAAACTATATCTTCATGGAAACATGCTTACTGGATTGATTCCTCCCGAGCTAGGAAACATGTCTAAACTGAGCTACCTGCAACTGAATGATAATCAACTGGTGGGTGAAATTCCTAACGAGTTCGGGAAGCTTGAGCATCTGTTTGAATTGAATCTTGCAAATAACCGTCTAAATGGATCTATTCCACATAACATAAGCTCCTGCACGGCCTTAAATCAGTTTAATGTGCATGGTAATCAGTTAAGCGGTTCTATTCCATTGAGCTTTCGCAAACTTGAGAGTTTGACTTACTTAAATCTCTCTGCGAACAACTTTAAAGGGATTATACCAGTTGAGTTAGGCCGTATCATAAATCTTGATACACTGGATCTATCTAGCAATAATTTTTCCGGTCATGTTCCAGCATCTGTTGGTTCCCTAGAGCATCTTTTGACCCTCAACCTGAGTCATAACCATCTCGATGGTCCATTGTCTGCTGAATTTGGGAATCTTAGAAGCATACAGATTATTGATATGTCCTTCAACAATCTGTCGGGTAGCATTCCTCCAGAAATTGGACAGCTGCAGAACCTTGCCTCTCTGATTTTGAACAACAATGACCTTCACGGGAAGATTCCGGAACAGCTCACCAATTGTTTCAGTCTTTCTTCCATGAATTTTTCTTATAACAACTTTACAGGAGCAGTTCCATCTAATAAGAACTTCACGCGGTTTCTGGCTGACAGTTTCTTTGGAAACCCTTTATTATGTGGAAATTGGATAGGATCCATATGCCGTCCTTATGTCCCGAAATCAAGAGAAATTTTTTCTAGAGTTGCAGTTGCATGTCTCACTCTTGGTATCATCGTGTTACTGGCTATGGTGATTATTGCTATATATAGATCCATCCAATCAAAGCAGTTGTTGAAAGCATCTAACATGTCCGACCAAGTGCCTCCCAAGCTTGTGGTTCTTCATATGGATTTGGCAATACACACTTTGGATGATATAATGAGAAGCACCGAAAATCTCAGTGAGAAATTTATCATAGGTTATGGTGCCTCTAGTACTGTATACAAGTGTGTGTTGAAAAATTCCCGACCGATTGCAGTCAAGCGATTGTACAATCAGCATCCACACAATTTAAGGGAATTCGAAACGGAACTTGTAACAATAGGCAGCATTAGGCATAGAAATCTTGTTGTTTTGCATGGCTATGCTCTTACTCCTTATGCAAATCTACTTTTTTACGAGTACATGGCAAACGGCTCTCTGTGGGATCTTCTACATGGTCCGCTTAAGGTAAAACTCGATTGGGAAACACGGATGAGGATTGCTGTTGGAGCTGCTGAAGGACTTGCTTATCTTCATCATGATTGCAACCCTCGAATTGTTCACAGGGACATTAAGTCTTCAAATATTTTGCTGGATGAAAACTTTGTGGCTCACCTTTCTGATTTTGGCACTGCAAAATGCATCCCGGCCACAAAAACTCACGCCTCAACTTATGTCCTAGGAACTATAGGCTATATTGATCCTGAATATGCACGAACTTCTAGGCTGAATGAGAAATCGGATGTATATAGCTTTGGCATTGTTCTGCTAGAGCTACTCACTGGGAAGAAGGCAGTGGATAATGATTCCAATTTGCATCAATTGATATTGTCCAAGGCTGACAATAACACTGTAATGGAAGCTGTGGATCCCGAGGTATCCGTTACCTGCGTTGATTTGGCTCATGTCAAGAAGACCTTTCAACTTGCTTTGCTATGCACAAAAAAGAACCCTTCTGAGAGGCCTACCATGCATGAAGTAACCAGGGTGCTTATTTCACTTCTTCCTGCACCTCCAAGTAAAGTCATTGCAGCTATGGGGAAGAGTTTCGACTATGCTCCTTTCGTGGTTGATAAGGGACAGCACCACCGAAAATTGGATGGACTACAACCTCAGTGCGATAACAACTCTTCTAATGCTCAATGGTTTGTTCGTTTCGGGGATGCTATATCCAAGAGCTCTCTCTGA | 2997 | 0.4041 | MVEEKGFVLLLYGAAEHKTRFSMFHTTLLFLVLLVLSPFAFSLTDEGQALMAMKSSFNNIADVLLDWDDVHNDDFCSWRGVFCDNVTLTVTVVSLNLSCLNLGGEISPAIGDLRNLQSIDLQGNKLTGQIPDEIGNCGELVHLDLSDNQLYGDIPFSISKLKLLEFLNLKNNQLTGPIPSTLSQIPNLKTIDLARNKFIGEIPRLLYWNEVLQYLGLRGNMLTGILSPDICQLTGLWYFDVRGNNLTGTIPESIGNCTSFEIFDISYNQITGEIPYNIGFLQVATLSLQGNRLTGKIPEVIGLMQALAILDLSENLLVGPIPPILGNLSFTGKLYLHGNMLTGLIPPELGNMSKLSYLQLNDNQLVGEIPNEFGKLEHLFELNLANNRLNGSIPHNISSCTALNQFNVHGNQLSGSIPLSFRKLESLTYLNLSANNFKGIIPVELGRIINLDTLDLSSNNFSGHVPASVGSLEHLLTLNLSHNHLDGPLSAEFGNLRSIQIIDMSFNNLSGSIPPEIGQLQNLASLILNNNDLHGKIPEQLTNCFSLSSMNFSYNNFTGAVPSNKNFTRFLADSFFGNPLLCGNWIGSICRPYVPKSREIFSRVAVACLTLGIIVLLAMVIIAIYRSIQSKQLLKASNMSDQVPPKLVVLHMDLAIHTLDDIMRSTENLSEKFIIGYGASSTVYKCVLKNSRPIAVKRLYNQHPHNLREFETELVTIGSIRHRNLVVLHGYALTPYANLLFYEYMANGSLWDLLHGPLKVKLDWETRMRIAVGAAEGLAYLHHDCNPRIVHRDIKSSNILLDENFVAHLSDFGTAKCIPATKTHASTYVLGTIGYIDPEYARTSRLNEKSDVYSFGIVLLELLTGKKAVDNDSNLHQLILSKADNNTVMEAVDPEVSVTCVDLAHVKKTFQLALLCTKKNPSERPTMHEVTRVLISLLPAPPSKVIAAMGKSFDYAPFVVDKGQHHRKLDGLQPQCDNNSSNAQWFVRFGDAISKSSL | 998 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa3g03044 | 998 | SMART | LRR_typ_2 | 472 | 495 | IPR003591 | - | |
Vifa3g03044 | 998 | SMART | LRR_typ_2 | 233 | 257 | IPR003591 | - | |
Vifa3g03044 | 998 | SMART | LRR_typ_2 | 113 | 137 | IPR003591 | - | |
Vifa3g03044 | 998 | SMART | LRR_typ_2 | 520 | 544 | IPR003591 | - | |
Vifa3g03044 | 998 | SMART | LRR_typ_2 | 376 | 400 | IPR003591 | - | |
Vifa3g03044 | 998 | SMART | LRR_typ_2 | 352 | 375 | IPR003591 | - | |
Vifa3g03044 | 998 | SMART | LRR_typ_2 | 424 | 447 | IPR003591 | - | |
Vifa3g03044 | 998 | SMART | LRR_typ_2 | 161 | 185 | IPR003591 | - | |
Vifa3g03044 | 998 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 640 | 744 | - | - | |
Vifa3g03044 | 998 | Pfam | Leucine Rich Repeat | 115 | 137 | IPR001611 | GO:0005515 | |
Vifa3g03044 | 998 | Pfam | Leucine rich repeat | 333 | 389 | IPR001611 | GO:0005515 | |
Vifa3g03044 | 998 | Pfam | Leucine rich repeat | 450 | 509 | IPR001611 | GO:0005515 | |
Vifa3g03044 | 998 | SUPERFAMILY | Protein kinase-like (PK-like) | 651 | 934 | IPR011009 | - | |
Vifa3g03044 | 998 | Gene3D | Transferase(Phosphotransferase) domain 1 | 745 | 943 | - | - | |
Vifa3g03044 | 998 | SUPERFAMILY | L domain-like | 327 | 583 | - | - | |
Vifa3g03044 | 998 | Gene3D | Ribonuclease Inhibitor | 43 | 210 | IPR032675 | - | |
Vifa3g03044 | 998 | FunFam | LRR receptor-like serine/threonine-protein kinase ERL1 | 320 | 593 | - | - | |
Vifa3g03044 | 998 | Pfam | Leucine rich repeat N-terminal domain | 45 | 84 | IPR013210 | - | |
Vifa3g03044 | 998 | Gene3D | Ribonuclease Inhibitor | 211 | 285 | IPR032675 | - | |
Vifa3g03044 | 998 | Gene3D | Ribonuclease Inhibitor | 286 | 592 | IPR032675 | - | |
Vifa3g03044 | 998 | PANTHER | OS04G0122200 PROTEIN | 92 | 203 | - | - | |
Vifa3g03044 | 998 | SMART | serkin_6 | 669 | 935 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa3g03044 | 998 | FunFam | LRR receptor-like serine/threonine-protein kinase ERL1 | 210 | 319 | - | - | |
Vifa3g03044 | 998 | FunFam | LRR receptor-like serine/threonine-protein kinase ERL1 | 43 | 209 | - | - | |
Vifa3g03044 | 998 | ProSiteProfiles | Protein kinase domain profile. | 669 | 938 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa3g03044 | 998 | Gene3D | Phosphorylase Kinase; domain 1 | 630 | 744 | - | - | |
Vifa3g03044 | 998 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 789 | 801 | IPR008271 | GO:0004672|GO:0006468 | |
Vifa3g03044 | 998 | ProSitePatterns | Protein kinases ATP-binding region signature. | 675 | 697 | IPR017441 | GO:0005524 | |
Vifa3g03044 | 998 | SUPERFAMILY | L domain-like | 43 | 339 | - | - | |
Vifa3g03044 | 998 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 745 | 944 | - | - | |
Vifa3g03044 | 998 | Pfam | Protein kinase domain | 673 | 931 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa3g03044 | Vifa-Chr3 | 873201120 | 873208057 | Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa3g03044 | 115 | 998 | Receptor kinase-like Gene Family | AT5G07180 | 75.819 | 0.0 | 1343 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XIIIb | Vifa3g03044 | Pkinase | 1.1e-42 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa3g03044 | K20718 | - | gmx:100811653 | 1652.11 |